ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
2,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
3,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
4,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
5,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
6,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
7,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
8,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
8,2,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
8,3,Electrocardiogram ST segment elevation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
8,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
8,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
9,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
10,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
11,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
12,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
13,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Cerebrovascular disorder,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
14,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
14,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
14,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
15,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
16,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
16,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
17,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
17,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
18,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
18,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
19,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
20,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
20,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
21,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
21,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
22,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
23,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
23,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
25,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
25,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
26,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
27,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
27,2,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
27,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
27,4,Congenital syphilitic osteochondritis,Bacterial infections congenital,Infections and infestations congenital,Cong,N
27,5,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
27,6,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
27,7,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
27,8,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
27,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
27,10,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
28,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
29,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
30,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,Y
31,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
32,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
33,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
33,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
34,1,Arterial rupture,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,Y
35,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
35,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
36,2,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
37,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
37,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
37,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
37,4,Right ventricular failure,Right ventricular failures,Heart failures,Card,N
38,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
39,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
39,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
40,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
40,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
40,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
41,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
41,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
41,3,Headache,Headaches NEC,Headaches,Nerv,N
42,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
43,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
44,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
45,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
45,2,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
46,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
46,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
46,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
46,4,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
46,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
47,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
48,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
49,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
50,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
51,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
52,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
52,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
53,1,Infusion site haemorrhage,Infusion site reactions,Administration site reactions,Genrl,N
53,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
53,3,Venous haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
54,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
54,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
54,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
54,4,Stridor,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
54,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
55,1,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
55,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
55,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
55,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
55,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
56,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
57,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
57,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
57,3,Swelling of eyelid,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
57,4,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
57,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
58,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
58,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
58,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
59,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
60,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
61,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
62,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
63,1,Diffuse alveolar damage,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
63,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
63,3,Idiopathic pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
63,4,Interstitial lung disease,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
63,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
64,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
65,1,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
65,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
66,1,Incorrect drug administration rate,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
66,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
67,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
68,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
68,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
68,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
68,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
68,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
68,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
69,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
70,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
70,2,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
70,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
70,4,Pancreatic haemorrhage,Pancreatic disorders NEC,Exocrine pancreas conditions,Gastr,N
70,5,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
71,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
72,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
72,2,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
73,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
73,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
74,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
74,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
74,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
74,4,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
74,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
75,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
75,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
75,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
76,1,Microangiopathic haemolytic anaemia,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
77,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
78,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
